RNS Number : 3189A

PuriCore Plc

28 September 2015



PuriCore plc

('PuriCore' or the 'Company')

Director Dealings

28 September 2015 -PuriCore plc(AIM: PURI), an international company focused on applying its proprietary hypochlorous acid platform technology to unmet needs in human health, today announces that on 24 September the following Directors notified the Company that they had purchased ordinary shares of 10p each in the share capital of the Company ('Shares') as set out below:

Name
Date purchased
Number of Shares purchased
Purchase price of Shares
Shareholding following the purchase
% of issued share capital
Charles Spicer
Non-Executive Chairman
24 September 2015
77,922
19.25p
152,922
0.31%
Daniel Hegglin Non-Executive Director
24 September 2015
500,000
19.30p
5,409,091
10.79%

-Ends-

Enquiries:

PuriCore plc
+44 (0) 20 3727 1000
Alex Martin, Chief Executive Officer
Marella Thorell, Chief Financial Officer and Chief Operating Officer
FTI Consulting
+44 (0) 20 3727 1000
Simon Conway / Mo Noonan / Victoria Foster Mitchell
N+1 Singer (Nominated Adviser & Broker)
+44 (0) 20 7496 3000
Aubrey Powell / Jen Boorer / Thomas Smale

About PuriCore

PuriCore is an international company, focused on developing and commercialising products based on its proprietary hypochlorous acid platform technology, to address significant unmet needs in human health. PuriCore's products are currently used in two broad market segments: Supermarket Retail and Health Sciences. PuriCore's products do not cause harm to human or animal life or to the environment. The Group is headquartered in Malvern, Pennsylvania.

In the Supermarket Retail segment, PuriCore's products are used by customers to enhance quality and freshness of produce and floral products. Product offerings include the Sterilox®Fresh Systems (capital equipment) that are installed at customer locations and allow for generation of the solution as needed at the store. ProduceFresh®is the Company's concentrate bottled version of the solution for produce application. Customers use FloraFresh®, also sold as a concentrate in bottled form, to improve the freshness of cut flowers. ProduceFresh and FloraFresh are diluted for use by customers through the Company's concentrate delivery systems.

In Health Sciences, PuriCore offers a range of products to manage a variety of skin and wound conditions under a medical device registration.


This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSEAENXASESEAF

distributed by